InvestorsHub Logo
icon url

BLight1911

05/04/18 12:26 PM

#17555 RE: laraz5 #17554

The CEO of a company took a salary? That's huge news? Amazing? I think so? Maybe?
icon url

rbd317

05/04/18 12:29 PM

#17556 RE: laraz5 #17554

so, he’s been milking the company since 2007? that erectile dysfunction qb stock is eating oncx for breakfast... soon, that pps will be way above this...
icon url

reaper247

05/05/18 1:25 AM

#17568 RE: laraz5 #17554

LOL, laraz… no. The real travesty is that people intentionally omit relevant information and misrepresent the circumstances behind ONCX.

Lets look at the entire passage that was only partially provided.

The base salary of Mr. Redman was $290,016 for the periods noted. A variable percentage of salary was paid each period depending on the available cash resources of the Company, and the remainder was deferred. During 2017, $290,016 was paid in cash and $0 was deferred. During 2016, $99,254 was paid in cash and $190,762 was deferred. Mr. Redman has agreed to defer payment of the unpaid amounts for these and prior years until such time as the Company has raised additional funds, and these unpaid amounts are reflected as deferred compensation in the Company’s financial statements.

If we look at deferred compensation in the financial statement in the filing you partially quoted, we see $1,268,013.

While some claim that ONCX is some kind of enrichment scheme, we can clearly see that Redman has only received a fraction of the salary he is owed. The overwhelming compensation due to Redman and Payne has been deferred.

Those are facts that cant be denied.

The same filing that we are both referencing, show that claims of BOD participating in a pyramid scheme by receiving cash and shares to be an outright lie.

During 2017 and 2016, the directors of the Company were not compensated for their services as directors and it is not expected that the directors will receive compensation in 2018, except as described below. Upon his appointment to the Board, Dr. Holaday was granted a warrant to acquire 900,000 shares of Common Stock at $0.09 per share. This warrant was initially exercisable for 1/3 of the shares, and 1/3 are exercisable on the first and second anniversary. The warrant expires on November 30, 2022. Dr. Holaday will also be paid $1,000 per month of service. The Company has no other formal arrangement pursuant to which directors are compensated for their services in their capacity as directors, but expects to adopt a policy in 2018 for independent directors. Directors are reimbursed for reasonable out of pocket expenses incurred.


These are absolute facts based on open source, public information.

Arguments to the contrary are dumb conversations to try to have.

IMO and FWIW.